A
Assembly Biosciences, Inc. (ASMB)
NMS – Real Time Price. Currency in USD
27.70
-1.17 (-4.05%)
At close: Mar 27, 2026, 4:00 PM EDT
27.16
-0.54 (-1.95%)
After-hours: Mar 27, 2026, 7:15 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
27.70
-1.17 (-4.05%)
At close: Mar 27, 2026, 4:00 PM EDT
27.16
-0.54 (-1.95%)
After-hours: Mar 27, 2026, 7:15 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.22 | 6.05 | 10 | |
| Quick ratio | 5.22 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 10 | |
| Weighted average score | 9.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 7M | 29M | 72M | 72M |
| Gross Profit | -498K | 7M | 28M | 72M | 72M |
| Operating Income | -93M | -65M | -45M | -12M | -12M |
| Net Income | -93M | -61M | -40M | -6M | -6M |
| EBITDA | -93M | -64M | -45M | -12M | -12M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -1.31 | 38 | 5.5 |
| Next quarter | -13.82 | 36.9 | 5.5 |
| Current year | -59.8 | -738.65 | 1.0 |
| Next year | 394.72 | 75.71 | 10 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 293.63 | 340.21 | 470.83 | 193.66 | 10 |
| Y/Y | 477.26 | 313.74 | 273.38 | 3592.14 | 10 |
| 3y average | 483.56 | 51.12 | 61.24 | -60.43 | 7.8 |
| 5y average | 251.72 | 14.55 | 29.66 | -44.2 | 7.3 |
| Weighted average score | 8.8 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $58.5M significantly exceed its total debt $2.6M, ensuring strong financial flexibility
Total current assets $254.5M exceed Total current liabilities $48.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
The company generates positive free cash flow $14.2M, supporting its financial health